CSPC Pharmaceutical's CRB-701 Earns FDA Fast Track Designation for Cervical Cancer Treatment
Company

CSPC Pharmaceutical’s CRB-701 Earns FDA Fast Track Designation for Cervical Cancer Treatment

Sisram Medical's Alma Harmony and Alma Hybrid Receive EU Medical Device Certification
CompanyMedical Device

Sisram Medical’s Alma Harmony and Alma Hybrid Receive EU Medical Device Certification

Shanghai Henlius Biotech's HLX11 Biosimilar Accepted for Review by China's CDE
CompanyDrug

Shanghai Henlius Biotech’s HLX11 Biosimilar Accepted for Review by China’s CDE

Wuhan Kaideweisi Biotechnology Secures Series B Funding for Gynecologic Oncology Expansion
CompanyDeals

Wuhan Kaideweisi Biotechnology Secures Series B Funding for Gynecologic Oncology Expansion

Shanghai Henlius Biotech's HLX22 Receives NMPA Approval for Phase II HER2-Targeted Study
CompanyDrug

Shanghai Henlius Biotech’s HLX22 Receives NMPA Approval for Phase II HER2-Targeted Study

Jiangsu Recbio Technology Secures Private Placement with Yangtze River Pharmaceutical for Vaccine Development
CompanyDeals

Jiangsu Recbio Technology Secures Private Placement with Yangtze River Pharmaceutical for Vaccine Development

Hangzhou Chance Pharmaceuticals Partners with Yiling Pharmaceutical for Inhalation Powder Development
CompanyDeals

Hangzhou Chance Pharmaceuticals Partners with Yiling Pharmaceutical for Inhalation Powder Development

GRIT Biotechnology and Vitalgen BioPharma Partner on CRISPR-AaCas12bMAX Cell Therapies
CompanyDeals

GRIT Biotechnology and Vitalgen BioPharma Partner on CRISPR-AaCas12bMAX Cell Therapies

YiChang HEC ChangJiang Pharmaceutical and DP Technology Deepen Partnership with AI Focus
CompanyDeals

YiChang HEC ChangJiang Pharmaceutical and DP Technology Deepen Partnership with AI Focus

Mabwell Bioscience Enters Licensing Agreement for Biosimilar Denosumab in Peru
CompanyDeals

Mabwell Bioscience Enters Licensing Agreement for Biosimilar Denosumab in Peru

Analytical BioSciences Sells Global Rights to Pre-Clinical Anti-Tumor Drugs to Gilead
CompanyDeals

Analytical BioSciences Sells Global Rights to Pre-Clinical Anti-Tumor Drugs to Gilead

"CanSino Biologics Partners with Etana for Inhaled Tuberculosis Vaccine Development
CompanyDeals

CanSino Biologics Partners with Etana for Inhaled Tuberculosis Vaccine Development